CD80 and neoplasm: RT significantly enhanced the abundance of tumor-infiltrating CD317+CD11c+ pDCs and the injection of PIC into the radiated tumors increased the percentage of CD80+ cells, one of the markers of TLR-9 activation, among pDCs, when compared to the untreated control group (Fig. 4g, h)36,43.